In addition, FGF21 exerts hepato-protective effects by promoting hepatic lipid and free fatty acid (FFA) metabolism, reducing hepatic adiposity, and ameliorating NAFLD and NASH (19, 22, 25–27). This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.